Physician profile
Sumit Som
NPI 1104082353
$36,452.40
in general payments reported to CMS, 2019-2025
47 companies · $1,756 in 2025
The $1,756 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $292 · 2021: $1,267 · 2022: $1,036 · 2023: $5,143 · 2024: $26K · 2025: $1,756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $23K · Food and Beverage: $5,621 · Consulting Fee: $3,780 · Travel and Lodging: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $22,680.00 |
| Food and Beverage | $5,621.42 |
| Consulting Fee | $3,780.00 |
| Travel and Lodging | $1,160.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $28,691.71 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,076.98 | 2020-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $863.48 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $715.15 | 2021-2025 | Verquvo |
| Abbott Laboratories | $582.06 | 2019-2024 | Cardiomems, Jot Dx, Xience Skypoint |
| Boston Scientific Corporation | $537.35 | 2019-2025 | Watchman Flx, Watchman, Watchman Access System |
| Medtronic, INC. | $357.59 | 2021-2024 | Onyx Frontier, Ffrangio |
| Amgen INC. | $341.96 | 2019-2025 | Repatha, Repatha, Otezla |
| Novo Nordisk INC | $258.29 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Heartflow, INC. | $246.14 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $246.13 | 2023-2025 | Amvuttra, Onpattro |
| Astrazeneca Pharmaceuticals LP | $243.94 | 2021-2025 | Farxiga |
| Pfizer INC. | $198.61 | 2022-2025 | |
| Shockwave Medical, INC | $183.02 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.76 | 2022-2025 | Lifevest |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Som listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.